1. Market Definition & Scope
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency and Limitation
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research / Interviews with Key Opinion Leaders of The Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for The Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Drivers
4.2.1.1. Growing Adoption of Continuous Bioprocessing
4.2.1.2. Recent Product Launches and Advances in the Continuous Bioprocessing Space
4.2.1.3. Initiatives Supporting the Adoption of Biopharmaceuticals
4.2.2. Restraints
4.2.2.1. Limitations of Continuous Bioprocessing
4.2.3. Opportunities
4.2.3.1. Shift Towards Bioprocessing 4.0
4.2.3.2. Rising Adoption of Personalized Medicine
4.2.4. Challenges
4.2.4.1. Manufacturers' Reluctance to Shift from Batch Manufacturing to Continuous Manufacturing
4.3. Market Trends
4.4. Parent Market Analysis: Bioprocessing Equipment and Consumables Market
4.5. Porter's Five Forces Analysis
4.5.1. Bargaining Power of Buyers
4.5.2. Bargaining Power of Suppliers
4.5.3. Threat of Substitutes
4.5.4. Threat of New Entrants
4.5.5. Degree of Competition
5. Europe Continuous Bioprocessing Market Assessment—by Product
5.1. Overview
5.2. Filtration Systems and Consumables
5.3. Chromatography Systems and Consumables
5.4. Cell Culture Media, Buffers, and Reagents
5.5. Incubators and Shakers
5.6. Bioreactors
5.7. Centrifuges
5.8. Sterilizers
5.9. Other Instruments and Consumables
6. Europe Continuous Bioprocessing Market Assessment—by Application
6.1. Overview
6.2. Commercial Applications
6.2.1. Monoclonal Antibodies (mAbs) Production
6.2.2. Cell and Gene Therapy Production
6.2.3. Vaccine Manufacturing
6.2.4. Plasma Fractionation
6.2.5. Recombinant Protein Production
6.3. Research & Development (R&D)
7. Europe Continuous Bioprocessing Market Assessment—by End User
7.1. Overview
7.2. Pharmaceutical and Biotechnology Companies
7.3. Contract Development and Manufacturing Organizations (CDMOS) and Contract Research Organizations (CROS)
7.4. Academic and Research Institutes
8. Europe Continuous Bioprocessing Market Assessment—by Country
8.1. Overview
8.2. Germany
8.3. U.K.
8.4. France
8.5. Spain
8.6. Italy
8.7. Switzerland
8.8. Netherlands
8.9. Belgium
8.10. Denmark
8.11. Ireland
8.12. Rest of Europe (RoE)
9. Competition Analysis
9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Market Share Analysis, by Key Players (2022)
10. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)
10.1. 3M Company
10.2. Thermo Fisher Scientific Inc.
10.3. Sartorius AG
10.4. Eppendorf AG
10.5. Pall Corporation
10.6. Cytiva
10.7. Merck KGAA
10.8. Repligen Corporation
10.9. Applikon Biotechnology
10.10. Bionet
10.11. Solida Biotech GmBH
10.12. Electrolab Biotech Limited
10.13. Biowest
(Note: SWOT analysis is provided for the top 5 companies)
11. Appendix
11.1. Available Customization
11.2. Related Reports
List of Table
Table 1 Europe Continuous Bioprocessing Market, by Product, 2021-2030 (USD Million)
Table 2 Key Companies Offering Filtration Systems and Consumables
Table 3 Filtration Systems and Consumables Market, by Country, 2021-2030 (USD Million)
Table 4 Key Companies Offering Chromatography Systems and Consumables
Table 5 Cell Culture Media, Buffers, and Reagents Market, by Country, 2021-2030 (USD Million)
Table 6 Key Companies Offering Cell Culture Media, Buffers, and Reagents
Table 7 Incubators and Shakers Market, by Country, 2021-2030 (USD Million)
Table 8 Key Companies Offering Incubators and Shakers
Table 9 Bioreactors Market, by Country, 2021-2030 (USD Million)
Table 10 Key Companies Offering Bioreactors
Table 11 Incubators Market, by Country, 2021-2030 (USD Million)
Table 12 Key Companies Offering Incubators
Table 13 Centrifuges Market, by Country, 2021-2030 (USD Million)
Table 14 Key Companies Offering Centrifuges
Table 15 Sterilizers Market, by Country, 2021-2030 (USD Million)
Table 16 Key Companies Offering Sterilizers
Table 17 Other Instruments and Consumables Market, by Country, 2021-2030 (USD Million)
Table 18 Key Companies Offering Other Instruments and Consumables
Table 19 Europe Continuous Bioprocessing Market, by Application, 2021-2030 (USD Million)
Table 20 Europe Continuous Bioprocessing Market for Commercial Applications, by Country, 2021-2030 (USD Million)
Table 21 Europe Continuous Bioprocessing Market for Monoclonal Antibodies Production, by Country, 2021-2030 (USD Million)
Table 22 Europe Continuous Bioprocessing Market for Cell and Gene Therapy Production, by Country, 2021-2030 (USD Million)
Table 23 Europe Continuous Bioprocessing Market for Plasma Fractionation, by Country, 2021-2030 (USD Million)
Table 24 Europe Continuous Bioprocessing Market for Recombinant Protein Production, by Country, 2021-2030 (USD Million)
Table 25 Europe Continuous Bioprocessing Market for R&D Application, by Country, 2021-2030 (USD Million)
Table 26 Europe Continuous Bioprocessing Market, by End User, 2021-2030 (USD Million)
Table 27 Europe Continuous Bioprocessing Market for Pharmaceutical and Biotechnology Companies, by Country, 2021-2030 (USD Million)
Table 28 Europe Continuous Bioprocessing Market for Contract Development and Manufacturing Organizations and Contract Research Organizations, by Country, 2021-2030 (USD Million)
Table 29 Europe Continuous Bioprocessing Market for Academic and Research Institutes, by Country, 2021-2030 (USD Million)
Table 30 Europe: Continuous Bioprocessing Market, by Country, 2021-2030 (USD Million)
Table 31 Europe: Continuous Bioprocessing Market, by Product, 2021-2030 (USD Million)
Table 32 Europe: Continuous Bioprocessing Market, by Application, 2021-2030 (USD Million)
Table 33 Europe: Continuous Bioprocessing Market for Commercial Applications, by Type, 2021-2030 (USD Million)
Table 34 Europe: Continuous Bioprocessing Market, by End User, 2021-2030 (USD Million)
Table 35 Germany: Continuous Bioprocessing Market, by Product, 2021-2030 (USD Million)
Table 36 Germany: Continuous Bioprocessing Market, by Application, 2021-2030 (USD Million)
Table 37 Germany: Continuous Bioprocessing Market for Commercial Applications, by Type, 2021-2030 (USD Million)
Table 38 Germany: Continuous Bioprocessing Market, by End User, 2021-2030 (USD Million)
Table 39 U.K.: Continuous Bioprocessing Market, by Product, 2021-2030 (USD Million)
Table 40 U.K.: Continuous Bioprocessing Market, by Application, 2021-2030 (USD Million)
Table 41 U.K.: Continuous Bioprocessing Market for Commercial Applications, by Type, 2021-2030 (USD Million)
Table 42 U.K.: Continuous Bioprocessing Market, by End User, 2021-2030 (USD Million)
Table 43 France: Continuous Bioprocessing Market, by Product, 2021-2030 (USD Million)
Table 44 France: Continuous Bioprocessing Market, by Application, 2021-2030 (USD Million)
Table 45 France: Continuous Bioprocessing Market for Commercial Applications, by Type, 2021-2030 (USD Million)
Table 46 France: Continuous Bioprocessing Market, by End User, 2021-2030 (USD Million)
Table 47 Spain: Continuous Bioprocessing Market, by Product, 2021-2030 (USD Million)
Table 48 Spain: Continuous Bioprocessing Market, by Application, 2021-2030 (USD Million)
Table 49 Spain: Continuous Bioprocessing Market for Commercial Applications, by Type, 2021-2030 (USD Million)
Table 50 Spain: Continuous Bioprocessing Market, by End User, 2021-2030 (USD Million)
Table 51 Italy: Continuous Bioprocessing Market, by Product, 2021-2030 (USD Million)
Table 52 Italy: Continuous Bioprocessing Market, by Application, 2021-2030 (USD Million)
Table 53 Italy: Continuous Bioprocessing Market for Commercial Applications, by Type, 2021-2030 (USD Million)
Table 54 Italy: Continuous Bioprocessing Market, by End User, 2021-2030 (USD Million)
Table 55 Switzerland: Continuous Bioprocessing Market, by Product, 2021-2030 (USD Million)
Table 56 Switzerland: Continuous Bioprocessing Market, by Application, 2021-2030 (USD Million)
Table 57 Switzerland: Continuous Bioprocessing Market for Commercial Applications, by Type, 2021-2030 (USD Million)
Table 58 Switzerland: Continuous Bioprocessing Market, by End User, 2021-2030 (USD Million)
Table 59 Netherlands: Continuous Bioprocessing Market, by Product, 2021-2030 (USD Million)
Table 60 Netherlands: Continuous Bioprocessing Market, by Application, 2021-2030 (USD Million)
Table 61 Netherlands: Continuous Bioprocessing Market for Commercial Applications, by Type, 2021-2030 (USD Million)
Table 62 Netherlands: Continuous Bioprocessing Market, by End User, 2021-2030 (USD Million)
Table 63 Belgium: Continuous Bioprocessing Market, by Product, 2021-2030 (USD Million)
Table 64 Belgium: Continuous Bioprocessing Market, by Application, 2021-2030 (USD Million)
Table 65 Belgium: Continuous Bioprocessing Market for Commercial Applications, by Type, 2021-2030 (USD Million)
Table 66 Belgium: Continuous Bioprocessing Market, by End User, 2021-2030 (USD Million)
Table 67 Denmark: Continuous Bioprocessing Market, by Product, 2021-2030 (USD Million)
Table 68 Denmark: Continuous Bioprocessing Market, by Application, 2021-2030 (USD Million)
Table 69 Denmark: Continuous Bioprocessing Market for Commercial Applications, by Type, 2021-2030 (USD Million)
Table 70 Denmark: Continuous Bioprocessing Market, by End User, 2021-2030 (USD Million)
Table 71 Ireland: Continuous Bioprocessing Market, by Product, 2021-2030 (USD Million)
Table 72 Ireland: Continuous Bioprocessing Market, by Application, 2021-2030 (USD Million)
Table 73 Ireland: Continuous Bioprocessing Market for Commercial Applications, by Type, 2021-2030 (USD Million)
Table 74 Ireland: Continuous Bioprocessing Market, by End User, 2021-2030 (USD Million)
Table 75 RoE: Continuous Bioprocessing Market, by Product, 2021-2030 (USD Million)
Table 76 RoE: Continuous Bioprocessing Market, by Application, 2021-2030 (USD Million)
Table 77 RoE: Continuous Bioprocessing Market for Commercial Applications, by Type, 2021-2030 (USD Million)
Table 78 RoE: Continuous Bioprocessing Market, by End User, 2021-2030 (USD Million)
Table 79 Recent Developments, by Company, 2020-2023
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Europe Continuous Bioprocessing Market, by Product, 2021-2030 (USD Million)
Figure 8 Europe Continuous Bioprocessing Market, by Application, 2021-2030 (USD Million)
Figure 9 Europe Continuous Bioprocessing Market, by End User, 2021-2030 (USD Million)
Figure 10 Europe Continuous Bioprocessing Market, by Country, 2023 Vs. 2030 (USD Million)
Figure 11 Impact Analysis: Europe Continuous Bioprocessing Market
Figure 12 Europe Continuous Bioprocessing Market, by Product, 2023 Vs. 2030 (USD Million)
Figure 13 Europe Continuous Bioprocessing Market, by Application, 2023 Vs. 2030 (USD Million)
Figure 14 Europe Continuous Bioprocessing Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 15 Europe Continuous Bioprocessing Market, by Country, 2021-2030 (USD Million)
Figure 16 Europe: Telehealth Market Snapshot
Figure 17 Competitive Dashboard: Europe Continuous Bioprocessing Market
Figure 18 3M: Financial Overview (2022)
Figure 19 Thermo Fisher Scientific: Financial Overview (2022)
Figure 20 Sartorius AG: Financial Overview (2022)
Figure 21 Eppendorf AG: Financial Overview (2021)
Figure 22 Danaher Corporation: Financial Overview (2022)
Figure 23 General Electric Company: Financial Overview (2022)
Figure 24 Merck KGaA: Financial Overview (2022)
Figure 25 Getinge AB: Financial Overview (2022)
COVID-19
This report provides pre & post COVID-19 market estimates.